Stem Cell Agency Governing Board Meeting January 27, 2011

Jan 27, 2011
Main Location: 

Crowne Plaza SFO
1177 Airport Blvd
Burlingame, CA 94010

Call-in Information: 
URL: http://205.144.147.162/cgi-bin/confCast Conference ID#: 188058 NO PASSWORD REQUIRED If you need technical assistance, call the toll-free AT&T Conference Casting Support Help Line at 1-888-793-6118.

Stem Cell Agency Governing Board Meeting
 

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

4. Swearing in of new and returning Board Members.

REPORTS & DISCUSSION ITEMS

5. Chairman’s Report.

6. President’s Report.
Budget Report/Expenditure Report

CONSENT CALENDAR

7. Consideration of minutes from previous Board meetings.
7a. December 8th Meeting Minutes
7b. December 15h Meeting Minutes

ACTION ITEMS

8. Consideration of recommendations from Grants Working Group regarding applications submitted in response to RFA 10-02: CIRM Tools and Technology Awards II.

Extraordinary Petitions:
Application #1913
Application #1939
Application #1972
Application #1985
Application #2054

9. Consideration of recommendation regarding Early Translational II Research Application 1778 submitted in response to RFA 10-01

CLOSED SESSION

10. a. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

b. Discussion of confidential intellectual property or work product, prepublication data, financial information, and confidential scientific research or data relating to applications for RFA 10-02: CIRM Tools and Technology Awards II and Early Translational II Research Application 1778 (Health & Safety Code 125290.30(d) (3) (B) and (C)).

Public report of any action taken, if necessary, during closed session.

OPEN SESSION

11. Consideration of Proposal for CIRM Visiting Faculty Awards.

12. Consideration of determination that service by Patient Advocate members of the Grants Working Group, the Vice Chair of the Facilities Working Group, and the Co-Chair of the Standards Working Group requires an extraordinary commitment of time and adoption of administrative policy to implement stipend for such members.

13. Consideration of proposed new scientific members and/or alternates for Grants Working Group.

14. Consideration of plan for CIRM support for attendance at ISSCR annual meeting by Patient Advocates, CIRM Bridges Scholars and other CIRM funded early career scientists.

15. Consideration of proposed regulatory language/process for multiple payback alternative to warrant coverage for loans.
a.Memo re. Multiple Payback Alternative to Warrant Coverage for Loans
b. REG LANGUAGE / Actual regulatory language for Multiple Payback Alternative

16. Consideration of report and recommendations from Governance Subcommittee, including: (a) discussion regarding parameters/criteria for Chair and opportunity to seek input from the Board and (b) recommendation regarding CIRM’s response to request by Citizens’ Financial Accountability Oversight Committee to post Statements of Economic Interest (Form 700) and travel expense claims filed by members of the Board and CIRM’s executive staff.
16Ai Memo of Summary of Duties Parameters for Chair
16Aii Memo from Claire Pomeroy to Sherry Lansing 16Aiii Meeting Allocation Summary 2011 16B ICOC Memo- CFAOC Request to post Form 700

 


DISCUSSION ITEMS

17. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .

 

© 2013 California Institute for Regenerative Medicine